ImportRefusal LogoImportRefusal

Indo Gulf Trading Company

⚠️ Moderate Risk

FEI: 3004111937 • Mumbai, Maharashtra • INDIA

FEI

FEI Number

3004111937

📍

Location

Mumbai, Maharashtra

🇮🇳

Country

INDIA
🏢

Address

51 / 57 Dontad Street, , Mumbai, Maharashtra, India

Moderate Risk

FDA Import Risk Assessment

40.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
4
Unique Violations
4/8/2008
Latest Refusal
10/20/2003
Earliest Refusal

Score Breakdown

Violation Severity
78.3×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
8.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

Refusal History

DateProductViolationsDivision
4/8/2008
68YYY02HORSES ANIMAL DRUGS N.E.C.
72NEW VET DR
Cincinnati District Office (CIN-DO)
10/25/2005
63BCS27LEVALBUTEROL HCL (BRONCHODILATOR)
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
Seattle District Office (SEA-DO)
2/25/2004
65PCA02SILDENAFIL CITRATE (REGULATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
10/20/2003
65PDB02SILDENAFIL CITRATE (REGULATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Indo Gulf Trading Company's FDA import refusal history?

Indo Gulf Trading Company (FEI: 3004111937) has 4 FDA import refusal record(s) in our database, spanning from 10/20/2003 to 4/8/2008.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Indo Gulf Trading Company's FEI number is 3004111937.

What types of violations has Indo Gulf Trading Company received?

Indo Gulf Trading Company has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Indo Gulf Trading Company come from?

All FDA import refusal data for Indo Gulf Trading Company is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.